Persistent [tmco]
urinary [qlco]
Excretion [phsf]
5-Hydroxyindole acetic acid [orch]
Marker [clna]
Favorable [qlco]
Survival [acty]
Patients [podg]
Disseminated [spco]
Midgut [emst]
Carcinoid [neop]
tumours [neop]
Survival [acty]
Patients [podg]
Disseminated [spco]
Midgut [emst]
[M]Carcinoid tumours [neop]
Varies [inpr]
investigated [ftcn]
Survival [acty]
Referral [hlca]
urinary levels [ftcn]
Hydroxyindoleacetic Acid [orch]
Patients [podg]
Study [mnob]
Urine [bdsu]
Collected [idcn]
H+ [elii]
3 Months [tmco]
Order [inpr]
Measure [qnco]
5-Hydroxyindole acetic acid [orch]
Levels [qlco]
Multivariate Analyses [qnco]
Performed [ftcn]
months [tmco]
Survival [acty]
months [tmco]
Prognostic Factor [clna]
Survival [acty]
Age [orga]
Gamma-glutamyl transferase level [lbpr]
Increased [qnco]
HIAA [orch]
Levels [qlco]
mmol/mol Creatinine [qnco]
Hazard Ratio [qnco]
Increased [qnco]
5-Hydroxyindole acetic acid [orch]
P NOS [aapp, imft]
Survival [acty]
5-Hydroxyindole acetic acid [orch]
Dependent [qlco]
Hazard Ratio [qnco]
5-Hydroxyindole acetic acid [orch]
P NOS [aapp, imft]
Patients [podg]
Persistent [tmco]
Moderately [qlco]
Increased [qnco]
urinary levels [ftcn]
Hydroxyindoleacetic Acid [orch]
mmol/mol Creatinine [qnco]
Favorable [qlco]
LTD [ortf]
Reserve [acty]
